WHO ICTRP trial

The effect of prophylactic use of pethidine for anxiety and post procedural pain…

ACTRN12614001194651 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12614001194651
Public title The effect of prophylactic use of pethidine for anxiety and post procedural pain relief in patients undergoing percutaneous liver biopsy
Scientific title In patients undergoing percutaneous liver biopsy, do prophylactic use of pethidine, compared to no treatment, reduce the anxiety and post procedural pain relief
Primary sponsor Gastroenterology unit, Dunedin Hospital
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries New Zealand
Conditions Patient undergoing percutaneous liver biopsy; Patient undergoing percutaneous liver biopsy;Anaesthesiology - Pain management;Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and…
Interventions Patients undergoing percutaneous liver biopsy receive 50mg of intravenous pethidine and 10mg of intravenous metoclopramide as premedication.
Registration date Nov 13, 2014
Target size 100
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations